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ABSTRACT
We developed orthogonal ribosome mRNA pairs in
which the orthogonal ribosome (O-ribosome) spe-
cifically translates the orthogonal mRNA and the
orthogonal mRNA is not a substrate for cellular
ribosomes. O-ribosomes have been used to create
new cellular circuits to control gene expression in
new ways, they have been used to provide new
information about the ribosome, and they form a
crucial part of foundational technologies for
genetic code expansion and encoded and evolvable
polymer synthesis in cells. The production of
O-ribosomes in the cell makes it challenging to
study the properties of O-ribosomes in vitro,
because no method exists to purify functional
O-ribosomes from cellular ribosomes and other
cellular components. Here we present a method
for the affinity purification of O-ribosomes, via
tagging of the orthogonal 16S ribosomal RNA. We
demonstrate that the purified O-ribosomes are pure
by primer extension assays, and structurally
homogenous by gel electrophoresis and sucrose
gradients. We demonstrate the utility of this purifi-
cation method by providing a preliminary in vitro
characterization of Ribo-X, an O-ribosome
previously evolved for enhanced unnatural amino
acid incorporation in response to amber codons.
Our data suggest that the basis of Ribo-X’s in vivo
activity is a decreased affinity for RF1.
INTRODUCTION
Orthogonal, parallel and independent systems are a key
foundation for synthetic biology. The synthesis of
orthogonal systems that are uncoupled from evolutionary
constraints, and selectively abstracted from cellular regu-
lation, is an emerging approach to making biology more
amenable to engineering (1,2).
We have described the creation of orthogonal
ribosomes (O-ribosomes) that eﬃciently and speciﬁcally
direct translation from orthogonal mRNAs, (O-mRNA)
which are not substrates for natural ribosomes, in
Escherichia coli (3). Unlike natural ribosomes,
O-ribosomes are non-essential for cellular survival and
their activity can be measured, independently of that of
natural ribosomes, by the translation of orthogonal
messages. We have shown that O-ribosomes allow the
construction of translational AND and OR functions (4)
and the invention of transcription translation feed
forward loops in the cell (5). These genetic circuits have
allowed the temporal control of gene expression and the
introduction of information processing delays in ways that
are impossible using natural gene expression.
O-ribosomes have also been used to provide informa-
tion on natural ribosome function that would be diﬃcult
to obtain by using the natural ribosome alone. For
example, we have shown that the rrnB operon (from
which 16S rRNA and 23S rRNA are transcribed) can be
re-factored to allow the independent production of each
rRNA, thereby deﬁning the boundaries for the minimal
16S RNA transcript that can be processed for functional
ribosome production (5). Moreover, we have used
O-ribosomes to perform large-scale mutagenesis and selec-
tion experiments on nucleotides in the structurally deﬁned
6,000A ˚ 2 interface between the two subunits of the
ribosome (6). These experiments revealed that a subset
of the structurally deﬁned nucleotides in the ribosomal
subunit interface form ‘functional hotspots’ that are
disproportionately important.
Finally, O-ribosomes provide a crucial component
in orthogonal translation, an approach to writing
orthogonal genetic codes for synthesizing proteins con-
taining unnatural amino acids and ultimately the cellular
synthesis of entirely unnatural polymers. There are two
major challenges in encoding the incorporation of unnat-
ural amino acids into proteins. First, orthogonal
aminoacyl tRNA synthetase/tRNA pairs are required
that speciﬁcally use an unnatural amino acid. Second,
since each of the 64 triplet codons is used up encoding
natural protein synthesis, new codons are required with
which to encode unnatural amino acids. In several cases
orthogonal aminoacyl tRNA synthetases that use unnat-
ural amino acids have been developed allowing
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in response to the amber stop codon (7 9). However,
competition with release factor at the amber codon
limits the eﬃciency of amino acid incorporation on
cellular ribosomes to  20%. We showed that, while the
natural ribosome is responsible for synthesizing the
proteome and is intolerant to mutation, the O-ribosome
can be synthetically evolved in the laboratory (creating
Ribo-X) to allow near quantitative unnatural amino acid
incorporation in response to amber codons on the
orthogonal message (10). This work showed that it is
possible to diﬀerentiate the genetic code that is read by
two diﬀerent messages in the cell using orthogonal
translational components. In recent work, we have
shown that it is possible to evolve O-ribosomes (Ribo-Q)
that decode quadruplet codons using extended anticodon
tRNAs, that are poorly decoded by natural ribosomes.
This provides a series of blank codons on the orthogonal
message. We have combined Ribo-Q with mutually
orthogonal aminoacyl tRNA synthetase/tRNA pairs
that use distinct unnatural amino acids, to create a ﬁrst
generation orthogonal genetic code (11).
While much characterization of O-ribosome function
can be done in vivo, we have been interested in purifying
O-ribosomes from endogenous ribosomes and other
cellular components- to allow us to investigate the
properties of O-ribosomes and their mutants in vitro.T o
address this challenge we have developed a system for the
aﬃnity puriﬁcation of highly active in vivo assembled
O-ribosomes, which is based on methods reported for
the puriﬁcation of tagged wild-type ribosomes (12).
Here, we describe the method for purifying O-ribosomes
by aﬃnity tagging the orthogonal 16S ribosomal RNA.
We demonstrate that the tagging does not aﬀect
O-ribosome function in vivo and that the puriﬁed
ribosomes are pure and structurally homogenous, by
primer extension, gel electrophoresis and sucrose gradi-
ents. Moreover, we demonstrate that this system allows
the properties of O-ribosomes to be characterized
in vitro, by providing an initial characterization of the
eﬀects of mutations in ribo-X on ribosome:RF1
interactions.
MATERIALS AND METHODS
Bacterial strains, media and growth conditions
All cloning steps were performed in the E. coli strain
DH10B (F- mcrA  (mrr-hsdRMS-mcrBC)
u80lacZM15 lacX74 recA1 endA1 araD139 (ara,
leu)7697 galU galK - rpsL nupG). Subsequent expression
experiments were conducted in E.coli strain BL21-DE3
(Invitrogen) [F
  ompT hsdSB(r 
Bm 
B) gal dcm (DE3)].
Co-expression of O-mRNA and O-ribosome constructs
for the in vivo O-ribosome activity assay used the
Genehog strain (Invitrogen) [F- mcrA (mrr-hsdRMS-
mcrBC) u80lacZM15 lacX74 recA1 araD139 (ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG fhuA::IS2
(confers phage T1 resistance)]. Ribosome puriﬁcations
were performed from the MRE 600 strain (a natural
RNase 1-deﬁcient strain) (13). Cultures were grown
in LB or 2XTY liquid media as described in text.
The media was supplemented with ampicillin at
100mg/ml and/or kanamycin at 50mg/ml where necessary
unless described in text.
MS2-GST expression system
A mutated MS2 coat protein coding sequence containing
the FG mutation (amino acid residues 68 80 deleted, WT
numbering) to prevent oligomerization (14,15) and the
V29I mutation (wild-type numbering) to increase tag
binding aﬃnity (16,17) was ampliﬁed by PCR using
the primers MS2fwd (gcgcaGGATCCgcttctaactttact-
cagttcgttctcgtc) and MS2rev (gcgcaCTCGAG
ttagtagatgccggagtttgctgcgattg) bearing the XhoI (fwd),
BamHI (rev) restriction sites and subcloned into the
expression vector pGex 4T1 (GE Healthcare) (pBR322
origin, the ampicillin resistance and the GST gene expres-
sion given by the PTrc promoter) using these sites resulting
in a GST-MS2 construct expressed under the control of
the strong inducible PTrc promoter.
To express and purify GST-MS2, cultures were grown
overnight in non-inducing 2XTY liquid media and then
diluted to an OD600 of 0.1 in 2l of fresh 2XTY and grown
to an OD600 of 0.6, induced with IPTG (ﬁnal concentra-
tion 1mg/ml) and incubated (16h, 20 C, 220rpm).
Cultures were then pelleted, the pellets kept on ice and
resuspended in 50ml of ice-cold GST-MS2 lysis buﬀer
(20mM Tris–HCl pH 7.5, 150mM KCl, 2mM DTT,
5% glycerol, 6mM BME, 100mM Benzamidine, 100mM
PMSF) and lysed using an emulsiﬂux at 4 C. The lysates
were kept on ice and clariﬁed by centrifugation (1h,
20000rpm 4 C), in SS34 tubes (Beckman) and the
supernatant (40 45ml) applied to phosphate buﬀered
solution (PBS) (137mM NaCl, 2.7mM KCl, 10mM
Na2HPO4, 2mM NaHPO4) pre-incubated 10ml column
of 4b glutathione sepharose resin (GE Healthcare) (at
RT with a ﬂow rate of 0.5ml/min, washed with 100ml
of PBS (1ml/min) and GST-MS2 eluted with 40ml
GST-MS2 elution buﬀer (50mM Tris–HCl pH 8, 10mM
reduced glutathione). The elution was then dialyzed
(snakeskin dialysis tubing, Roche) in 3l of PBS containing
20% glycerol (16h, 4 C).The dialysis was repeated in the
same volume (2h, 4 C), and the protein separated into
aliquots and ﬂash frozen. The protein concentration
was measured and the protein purity determined by
SDS-PAGE gel.
Tag-ribosome expression system
The tag sequence was introduced into the O-16S by enzy-
matic inverse PCR. The template was pJC73-O-16S(3)
and the primers were Tagfwd (gcgcaGGTCTCA
gattacccatctttactagtCTTCTTTGCTGACGAGTGGCGG
ACGGGTGAG), Tagrev (gcgcaGGTCTCAaatcctc
atcaaaactagtCTTCTTCCTGTTACCGTTCGACTTGCA
TGTG), that contain BsaI sites. The PCR reaction mix
was digested with BsaI and DpnI, circularized by
ligation and transformed into E. coli DH10B.
pSC101*-O-ribosome-tag was created by subcloning the
entire tag-O-16S sequence into pSC101*-O-ribosome (10)
(which contains the O-1623S operon under the control of
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ﬂanking the O-16S gene. The Ribo-X mutations (10) were
subcloned into the O-ribosome-tag construct using the
unique Sca1 and Xba1 sites creating pSC101*-Ribo-
X-tag.
To express and purify actively translating tagged
O-ribosomes the pSC101*-O-ribosome-tag or
pSC101*-Ribo-X-tag constructs were co-transformed
with O-MBP-GST (10), plated onto LB-KA (containing
50mg/ml kanamycin and 50mg/ml ampicillin). The
cultures were grown overnight (16h, 20 C, 220rpm) in
2XTY-KA, diluted to an OD600 of 0.1 in 4L of fresh
2XTY-KA, grown to an OD600 of 0.9 (16h, 20 C,
220rpm). The cultures were then cooled at 4 C for 2h,
pelleted, and resuspended in 30ml of ribosome lysis buﬀer
(20mM Tris–HCl pH 7.5, 100mM NH4Cl, 10mM MgCl2,
0.5mM EDTA, 6mM BME, 100mM Benzamidine,
100mM PMSF). Cells were lysed using an emulsiﬂux at
4 C. The lysate were kept on ice and clariﬁed by
centrifugation (1h, 20000rpm 4 C, in SS34 tubes
(Beckman) and the supernatant (25ml) were puriﬁed for
the ribosome fraction by applying it to an ice-cold 35ml
sucrose cushion (20mM Tris–HCl pH 7.5, 500mM
NH4Cl, 10mM MgCl2, 0.5mM EDTA, 1.1M sucrose,
6mM BME, 100mM Benzamidine) in a Ti45 ultracentri-
fuge tube (Beckman) and the ribosome fraction sedi-
mented by centrifugation (18h, 37000rpm 4 C) to
reveal a glassy ribosome pellet. This pellet was used for
aﬃnity puriﬁcation of tagged ribosomes or further pro-
cessed for storage as described below. The glassy pellet
was rinsed with ice-cold ribosome lysis buﬀer and then
resuspended in 2ml ribosome lysis buﬀer by application
of the buﬀer and allowing the glassy pellet to dissolve on
ice. The ribosomes were diluted in ribosome binding buﬀer
(20mM Tris–HCl pH 7.5, 100mM NH4Cl and 10mM
MgCl2, 6mM BME, 100mM Benzamidine, 100mM
PMSF) to a total volume of 10ml, giving a ribosome con-
centration in 7 14mg/ml range (determined using the
conversion 1 A260=62mg). The ribosomes were split
into aliquots and ﬂash frozen for aﬃnity puriﬁcation.
RF1 expression system
To express RF1, the RF1expression plasmid from the
PURE expression system (18) was transformed into
BL21-DE3 and the cultures grown overnight (16h, 20 C,
220rpm) in 2XTY liquid media. The culture was diluted to
an OD600 of 0.1 in 2L of fresh 2XTY, grown to an OD600
of 0.9 (16h, 20 C, 220rpm) and cooled at 4 C for 2h.
Cultures were pelleted and resuspended in 50ml RF1
lysis buﬀer (50mM Na2HPO4 pH 8, 300mM NaCl), and
lysed at 4 C using an emulsiﬂux. The supernatant was
further diluted with RF1-lysis buﬀer to a total volume
of 150ml and applied (4 C, 5ml/min) to a 50ml
Ni-chelating fast ﬂow sepharose column (GE
Healthcare). The column was washed with 150ml of
RF1-wash buﬀer (50mM Na2HPO4, pH 8 300mM
NaCl, 10mM imidazole) and eluted using a gradient of
imidazole (upto 250mM imidazole) using RF1-elution
buﬀer (50mM Na2HPO4 pH 8, 300mM NaCl, 250mM
imidazole), the elution was collected in 5ml fractions. RF1
containing fractions were pooled and further puriﬁed
using a 300S gel ﬁltration column: the pooled fractions
were diluted into 300ml of RF1 buﬀer (5mM HEPES
pH 7.5, 50mM KCl, 100mM NH4Cl, 10mM MgCl2)
and separated into 5ml fractions using a 5ml/min ﬂow
rate. RF1 was precipitated by slowly stirring in
ammonium sulphate to a ﬁnal concentration of 50% and
incubating (16h, 4 C). The precipitated proteins were
resuspended in 500ml of RF1 buﬀer containing 50%
glycerol.
Tag MS2-GST aﬃnity measurements
The activity of MS2-GST for binding the tag was assayed
by ﬂuorescence anisotropy using the chemically
synthesized, ﬂuorescently labelled tag RNA (50 ﬂuorescein
GCGAGGATTACCCGC). The change in ﬂuorescence
anisotropy was measured (excitation wavelength 494nm,
emission 521nm) with the incremental addition of 10mM
Tag RNA to a 200mM solution of MS2-GST in ribosome
buﬀer (supplemented with 0.1mg/ml bovine serine
albumen). The measurements were performed in a
quartz cuvette with mixing. The change in ﬂuorescence
anisotropy (binding) with increasing RNA tag concentra-
tion was plotted and the Kd value extracted from a best-ﬁt.
Tag-O-ribosome in vivo translational activity
To determine the eﬀect of the tag on O-ribosome activity
we transformed pSC101*-O-ribosome or pSC101*-O-
ribosome-tag into Genehog E. coli containing the O-Cat
reporter (10). The cultures were grown overnight in LB
liquid media supplemented with 50mg/ml kanamycin and
25mg/ml tetracycline, diluted 10-fold into LB supple-
mented with 12.5mg/ml kanamycin and 6.25mg/ml tetra-
cycline, grown to mid log phase (3h, 37 C, 220rpm) and
then plated onto LB-agar supplemented with 12.5mg/ml
kanamycin and 6.25mg/ml tetracycline and a range of
chloramphenicol concentrations (0–1000mg/ml) and
incubated (overnight, 37 C).
Tagged O-ribosome aﬃnity puriﬁcation
Four milligrams of puriﬁed GST-MS2 was diluted in 40ml
of PBS and bound to 10ml of glutathione sepharose beads
(in PBS) by incubating with gentle mixing for 30min at
RT. The beads were pelleted by centrifugation (5min,
500rpm, 4 C) and washed; twice with 40ml of PBS and
twice with 40ml of ribosome binding buﬀer (20mM
Tris–HCl pH 7.5, 100mM NH4Cl and 10mM MgCl2,
6mM BME, 100mM benzamidine, 100mM PMSF).
The sucrose cushion puriﬁed glassy ribosome pellet was
resuspended in 40ml of ribosome binding buﬀer, added to
the pre-chilled beads and incubated (rocked gently for at
4 C for 1h). The beads were then washed three times with
40ml of ribosome binding buﬀer at 4 C; the wash steps
separated by 45min. The ﬁnal bead pellet was resuspended
in 10ml of ribosome buﬀer (20mM Tris–HCl pH 7.5,
100mM NH4Cl, 10mM MgCl2, 6mM BME, 100mM
Benzamidine, 100mM PMSF)+3mM RNA tag and
incubated (18h, gently rolling, 4 C).
The synthesized RNA Tag sequence [50PGCGAGGAU
CACCCGC, a known competitive ligand for MS2 (16)]
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heating to 98 C and slow cooling to RT, it was then
diluted in ribosome binding buﬀer to a concentration
3mM and used to elute the bound ribosomes 10ml of
the 3mM RNA tag solution (4 C) was added to the
washed beads and incubated (18h, gentle rolling, 4 C).
The eluted ribosomes were separated from the beads
by pelleting the beads (20min, 4000rpm, 4 C). Any
remaining beads were removed from the supernatant by
ﬁltering through a 0.2mM ﬁlter.
The tagged O-ribosomes were concentrated using a
30000Da molecular weight cut-oﬀ Amicon concentrator
(Millipore), pre-equilibrated with ribosome buﬀer+5%
Tween, by centrifugation (4 C, 2000rpm) to a ﬁnal
volume of  500ml, split into aliquots and ﬂash frozen.
Characterization of aﬃnity puriﬁed tag-ribosomes
The purity of the aﬃnity puriﬁed tagged O-ribosome was
assayed by reverse transcription (12). The template rRNA
was prepared by taking a 50–100mg aliquot of
concentrated eluted ribosomes or ribosomal RNA
extracted using Trizol (Invitrogen), according to the man-
ufactures instructions. The RT primer (GGCCATGATA
CTTGAC) used was gel puriﬁed and subsequently
32P
labelled (5ml reaction mixture consisting of 5mMo fR T
primer, 3.36pmols g-
32P ATP, 1  PNK buﬀer (NEB) and
3U polynucleotide kinase (NEB) and incubated at 37 C
for 45min followed by 65 C for 15min). One microlitre of
this labelled primer mixture and 1mg of template was then
added to a 50ml reaction mixture consisting of 1  super-
script 3 buﬀer (Invitrogen), 5mM DTT, 100mM ddATP,
dGTP, dTTP, dCTP. Annealing was performed by
incubating the mixture at 94 C for 2min followed by a
temperature gradient down to 25 C at 0.1 C/s, 200U
Superscript 3 (Invitrogen) was then added and extension
preformed by incubating at 50 C 16h. The completed RT
reaction was mixed with a equal volume of formamide
running buﬀer (5% sucrose, 0.1% bromophenol blue,
formamide) incubated at 85 C for 15min and 2–5ml
loaded onto a denaturing gel [10% formamide, 20%
acylamide, 1  TBE (90mM Tris–Borate 2mM EDTA)]
run at 37W for 2.5h using 1  TBE running buﬀer. The
gel was imaged using a Typhoon scanner and the intensity
of the bands analyzed using the Image Quant TL program
(GE Health Care).
The integrity of the eluted ribosomes was determined by
non-denaturing electrophoresis [gel: 0.5% agarose, 3%
acylamide, 1  TBM (89mM tris base, 89mM boric acid
1mM MgCl2)]. The gel was pre-run (1h, 4 C, 100V) in 1 
TBM running buﬀer, the running buﬀer changed for fresh
running buﬀer, and 0.1–2 OD260 of the eluted ribosomes
[diluted in a equal volume of non-denaturing loading
buﬀer (20% sucrose, 1  TBM, 0.1% bromophenol
blue)] loaded. Gels were run for 2h, (4 C, 100V) before
visualizing the nucleic acids by incubating in 10mg/ml
ethidium bromide for 10min and then imaging under UV.
Analytical sucrose gradients were also used to look at
the integrity of puriﬁed ribosomes. An analytical sucrose
gradient was prepared with 15% and 30% (w/v) sucrose in
ribosome buﬀer. These two solutions were added to a
gradient pourer to pour even 13ml 15–30% sucrose gra-
dients in 40Ti tubes. The gradients were cooled to 4 C and
then 2 OD260 of the ribosome preparations were carefully
added to the very top layer of the gradients. The gradients
were spun (20h, 20500rpm, 4 C) and slowly removed
from the bottom of the tubes through a ﬁne needle. The
OD254 was measured along the gradient to give the
gradient proﬁle.
Preparation of tRNAfMet-[
3H]fMet for the RF1
termination assay (19)
To prepare tRNAfMet-[
3H]fMet the tRNAfmet was ﬁrst
aminoacylated with [
3H]Met. A 200ml reaction mix con-
sisting of 1  fMet reaction buﬀer (20mM Tris–HCl
pH 7.5, 7mM MgCl2, 150mM KCl), 12mM L-[
3H]Met,
4mM ATP (pH7), 80mM tRNAfmet and 1mM MetRS was
incubated (15min, 37 C). The reaction was driven to com-
pletion by quenching with a high concentration of cold
fMet; so the reaction mix was then supplemented with
15mmol of fMet, a volume of reaction buﬀer to keep the
buﬀer concentration constant and 0.4mMoles of ATP and
incubated (15min, 37 C).
The charged tRNAfmet-Met was formylated by the
addition of 4ml of formyl donor (preparation is described
below) (N5H10 methenyl-tetrahydrofolic acid) and 5mMo f
formylase. This reaction mix was then incubated (15min,
37 C).
The formyl donor was prepared by dissolving 100mg
folinic acid calcium salt in 8ml of 50mM
b-mercaptoethanol, adding 880ml of 1M HCl and
incubating for 3h. This is frozen and before use, 100ml
thawed on ice and 10ml of 1M Tris–HCl pH 8 and 10ml
1M KOH added, vortexed and incubated at RT for
20min and any precipitation removed by centrifugation.
The tRNAfMet-[
3H]fMet mixture was then phenol/chlo-
roform (pH 4.3) extracted, ethanol precipitated and
resuspended in 50ml of tRNA storage buﬀer (10mM
Ammonium acetate pH 5, 50mM KCl). Finally the
aminoacylated tRNA was desalted using a Sephadex
G25 column (GE), pre-equilibrated with tRNA storage
buﬀer, by centrifugation at 7000g for 2min. The speciﬁc
activity was calculated by measuring the RNA concentra-
tion (OD260, Mr 25000Da) and the scintillation counts
(1ml of puriﬁed tRNAfMet-[
3H]fMet was added to 3.8ml
of scintillation ﬂuid [Fluoran-safer 2 (BDH)] in triplicate
and
3H counted (Beckham LS6000SC).
In vitro RF1 termination assay
The initiation complex/pre-termination complex was
assembled as described (19), by incubation (37 C,
20min) of a reaction mix of 1mM puriﬁed ribosome,
2mM O-mRNA amber (50P GCGGCCGCUUUCAUAU
CCCUCCGCAAAUGUAGUUU) or mRNA amber
(50P AGGAGGUGAGGUAUGUAGUUU), 2mM
tRNAfMet-[
3H]fMet in ribosome buﬀer (20mM Tris–HCl
pH 7.5, 100mM NH4Cl, 10mM MgCl2, 6mM BME,
100mM Benzamidine, 100mM PMSF) (either 50 or
100ml). 0.1mg/ml BSA was added to the ribosome buﬀer
for the reactions and RF1 dilutions.
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(19), initial experiments were performed with saturating
concentration of RF1 and [
3H]fMet release measured by
ﬁlter binding. RF1 was added to the 50 or 100ml
pre-termination reaction mix to a ﬁnal concentration of
5mM, a control was also prepared where no RF1 was
added (incubated in parallel to control for spontaneous
tRNAfMet-[
3H]fMet hydrolysis). The incubation was
continued at 37 C, 15ml aliquots were then removed at
1, 5 and 20min, added to 1ml of ice-cold ribosome
buﬀer, separated into three replicates and added to a
nitrocellulose ﬁlter pre-soaked in ribosome buﬀer,
washed three times with 900ml of ribosome buﬀer, air
dried and added to 3.8ml of scintillation ﬂuid and the
bound
3H counted. This measures the amount of
ribosome bound [
3H]fMet.
Subsequent experiments were performed with a range
of RF1 concentrations and measured [
3H]fMet release.
The pre-termination complex was assembled as described
above and split into 18ml aliquots in a row of a 96-well
plate, with the next row containing 2ml of RF1 at various
concentrations in ribosome buﬀer. A no RF1 control con-
taining only ribosome buﬀer was also prepared. The plate
was incubated at 37 C for 2min to equilibrate the solution
to the reaction temperature. To start the reaction the
pre-termination complex was added to the RF1 samples
using a multi-channel pipette and mixed rapidly. After
10s, 200ml of ice-cold 5% TCA (trichloroacetic acid)
was added to quench the reaction and precipitate the
complex and unhydrolyzed tRNAfMet-[
3H]fMet leaving
hydrolyzed [
3H]fMet in solution. 200ml of the quenched
reaction was removed and added to 800ml ice-cold 5%
TCA and mixed thoroughly. The sample was then spun
(20min, 25000g, 4 C) and the top 650ml removed split
into three replicates, added to 3.8ml scintillation ﬂuid
and
3H counted.
Figure 1. Design of the ribosome RNA aﬃnity tag. The structure of the 70S ribosome (21) showing the position of the tag (shown in red) with the
30S shown in yellow and the 50S in grey. The position and sequence of the tag in the 16S secondary sequence is shown below. The blue nucleotides
are the linker sequence and the aﬃnity tag is shown in green (12).
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Tagged O-ribosomes are active in vivo and can be
aﬃnity puriﬁed
To provide a molecular handle with which to purify the
O-ribosome from cells we introduced the MS2 stem loop
tag into the O-16S rRNA in place of nucleotides 83–86
(Figure 1). Previous work has shown that introducing this
sequence into wild-type 16S rRNA does not interfere with
the activity of endogenous ribosomes (12).
To demonstrate that the tag does not aﬀect the activity
of O-ribosomes we measured the chloramphenicol resis-
tance of cells containing the O-cat reporter (which
contains the chloramphenicol acetyl-transferase gene on
an O-ribosome binding site) and the tagged and
untagged O-ribosome (produced from pSC101*-O-
ribosome and pSC101*-O-ribosome-tag). Both tagged
and untagged O-ribosomes support growth to 600mg/ml
(data not shown) demonstrating that the tag has no mea-
surable eﬀect on translational eﬃciency, within the limits
of this assay.
To produce tagged O-ribosomes for puriﬁcation
MRE600 E. coli containing pO-GST-MBP(10) (a vector
containing GST-MBP expressed from an O-ribosome
binding site) and the relevant ribosome construct (10)
were grown at 20 C, the growth cooled to 4 C, lysed
using an emulsiﬂux and the lysate clariﬁed by
centrifugation. To prepare crude ribosomes the lysates
were applied to a sucrose cushion, the resulting glassy
ribosome pellet resuspended and used in the aﬃnity
puriﬁcations.
To purify the tagged O-ribosomes from cellular
ribosomes (Figure 2) we bound total ribosomes to
glutathione sepharose coated with MS2-GST (we con-
ﬁrmed the activity of our MS2-GST preparations by mea-
suring its aﬃnity for ﬂuorescently labelled MS2-tag RNA
by ﬂuorescence anisotropy), and washed away endogenous
ribosomes. To speciﬁcally elute the tagged O-ribosomes we
ﬁrst tried glutathione, as previously reported for wild-type
ribosomes (12). This method worked, leading to the elution
of stable GST-MS2:ribosome-tag complexes [eluted
ribosomes were tagged as measured by allele speciﬁc
primer extension (12) (data not shown)]. However, since
the GST-MS2 fusion is large the GST-MS2:30S and
GST-MS2:70S complexes eluted are shifted in sucrose
gradient proﬁles, relative to the normal 30S and 70S
peak positions. This leads to the GST-MS2:30S peak
overlapping with the 50S peak, making sucrose gradient
proﬁles diﬃcult to interpret. Moreover, we found that
aggregates formed in the elution, presumably as a result
of multimerization via GST, MS2 or both, making it diﬃ-
cult to quantify the soluble ribosome concentration accu-
rately for downstream assays. These issues made the
method challenging for purifying tagged ribosomes,
whether orthogonal or wild-type.
Ideally, tagged ribosomes could be speciﬁcally eluted
without the large GST-MS2 tag. This would give normal
sucrose gradient proﬁles for the tagged ribosome, avoid
multimerization and aggregation and avoid attaching a
large protein fusion to the ribosome for further assays.
To address this challenge, we eluted bound ribosomes
with a chemically synthesized MS2-RNA hairpin.
Moreover, in our ﬁnal protocol we optimized several
critical parameters to preserve the structural integrity of
tagged ribosomes during puriﬁcation: a batch aﬃnity puri-
ﬁcation was used and the entire puriﬁcation was done at
4 C to further stabilize ribosome structure.
Initially, the eﬀectiveness of the modiﬁed protocol in
producing a pure pool of tagged O-ribosome from
Figure 2. O-ribosome aﬃnity puriﬁcation strategy. Initial binding of
the tagged O-ribosome to glutathione bound GST-MS2 is followed
by elution using the RNA tag sequence.
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extension assay. Subsequently to ensure the presence of
the tag and the modiﬁed puriﬁcation process does not
interfere with ribosome function in vitro we assayed the
structural integrity and termination activity of eluted
tagged-O-ribosomes, using untagged wild-type ribosomes
as a control.
O-ribosomes puriﬁed using the MS2 system are 95% pure
To assess the purity of eluted tagged O-ribosomes, we
took advantage of the C1192U spectinomycin resistance
mutation in the tagged O-ribosome constructs for
allele-speciﬁc primer extension (20). An oligonucleotide
probe complementary to nucleotides 1193–1209 was
extended in the presence of ddATP giving rise to a +1
species for tagged O-ribosomes and a +4 species for
endogenous ribosomes (Figure 3a). RNA was extracted
from ribosomes and primer extension performed using a
50-[
32P] labelled primer. The primer extension products
were resolved on a denaturing polyacrylamide gel and
the relative intensities of the bands resulting from tagged
and untagged ribosomes quantiﬁed. The ratio of extension
product demonstrates that, following the MS2 puriﬁcation
method, the tagged O-ribosome pool is  95 % pure.
5‘GGCCATGAT GAC TTGAC
CCGGUACUACUGAACUGCAGUA
5‘GGCCATGAT GAC TTGACGTCA
CCGGUACUACUGAACUGCAGUA
5‘GGCCATGAT GAC TTGAC
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5‘GGCCATGAT GAC TTGACA
CCGGUACUACUGAACUGUAGUA
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Figure 3. Characterization of aﬃnity puriﬁed tagged O-ribosomes. (a) Purity of eluted O-ribosome measured by allele-speciﬁc primer extension.
(b) Analytical sucrose gradient proﬁles of untagged wild-type and puriﬁed tagged O-ribosome. (c) Non-denaturing gel separation the indicated
ribosomes.
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To further investigate the integrity of MS2 puriﬁed
ribosomes, we compared the eluted tagged O-ribosomes
with untagged wild-type control ribosomes using analyti-
cal sucrose gradient separation (Figure 3b) and
non-denaturing gel electrophoresis (Figure 3c).
The wild-type ribosome sucrose gradient proﬁle,
separated at a high magnesium concentration reveals a
large 70S peak, a 50S peak and a small 30S peak
(Figure 3b). In comparison, the puriﬁed orthogonal
tagged O-ribosome reveals a proﬁle with a sharp 70S
peak, increased 30S and no 50S peak. This further
conﬁrms the success of the puriﬁcation, since the tag is
in the 16S rRNA and should only facilitate puriﬁcation
of 30S and 70S, while free 50S should be washed away.
Non-denaturing gel electrophoresis (Figure 3c) of the
puriﬁed tagged O-ribosome (which dissociates the
subunits, but keeps the majority of proteins associated
with the ribosome) reveals strong 30S and 50S bands
and a similar pattern of additional bands to untagged
wild-type ribosome control. Taken together these data
suggest that we have been able to purify soluble, intact
O-ribosomes.
Tagged O-ribosomes show comparable in vitro
termination activity to wild-type ribosomes
Since we wanted to use puriﬁed tagged O-ribosomes to
investigate the molecular basis for enhanced eﬃciency
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Figure 4. In vitro termination assays reveal that Ribo-X has a decreased aﬃnity for RF1. (a) Schematic of termination assays. A complex of the
O-ribosome with an initiator tRNA aminoacylated with
35S formyl-methionine (red circle) is assembled (Step 1), in subsequent rounds this requires
dissociation of deacetylated tRNA. RF1 is added (Step 2) directing hydrolysis of
35S formyl-methionine from the tRNA (Step 3). RF1 dissociates
(Step 4). The ﬁlter-binding assay measures the ribosome associated
35S, while the TCA precipitation measures the
35S released (b) RF1 termination
activity measured in vitro with untagged wild-type and puriﬁed tagged O-ribosome, using ﬁlter-binding assays. (c) O-ribosome and Ribo-X termi-
nation activity with RF1. Measurement of initial rate of tRNA-fMet hydrolysis over a range of RF1 concentrations is shown for O-ribosome and
Ribo-X. RF1 concentration was increased till there was a measurable release in fMet and this release plotted. tRNA-fMet hydrolysis (37 C, 10s) is
measured by TCA precipitation.
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amber stop codon by Ribo-X(10) we were interested in
benchmarking the release factor mediated termination
activity of the tagged O-ribosome against wild-type
ribosomes.
We compared the eluted tagged O-ribosome and
untagged wild-type ribosomes using an in vitro termina-
tion assay (19) in which an mRNA (containing a ribosome
binding site followed by a start codon immediately
followed by an amber stop codon) is assembled with a
ribosome and [
3H]fMet-tRNAfMet in the P-site, creating
the pre-termination complex. RF1 is added to this
complex to initiate termination. RF1 binds to the A site
amber stop codon and catalyzes the hydrolysis of P-site
[
3H]fMet from tRNAfMet (Figure 4a). The maximum
amount of [
3H]fMet that can be released is determined
in a ﬁlter binding assay, using saturating concentration
of RF1 (Figure 4a). This is a measure of the size
of the ribosome pool that is competent to bind
[
3H]fMet-tRNAfMet, RF1 and catalyze the release of
[
3H]fMet. We observed similar activity for untagged
wild-type and puriﬁed tagged O-ribosomes in this assay.
This indicates that the puriﬁed tagged O-ribosomes have
comparable termination activity to wild-type ribosomes
(Figure 4b).
Ribo-X has a decreased aﬃnity for RF1
Finally, we used our method to prepare O-ribosomes and
Ribo-X for functional comparison using the RF1 termi-
nation assay. The assay was performed over a range of
RF1 concentrations and initial rates measured using TCA
precipitation (Figure 4a). In our preliminary experiments
we observe a substantial diﬀerence in RF1 activity with
the O-ribosome and Ribo-X (Figure 4c). With
O-ribosomes half-maximal termination is observed at an
RF1 concentration between 0.125 and 0.25nM. In
contrast, under identical conditions, the same amount of
fMet release with Ribo-X requires a concentration of RF1
of between 2 and 4nM. The maximal catalytic activity of
Ribo-X at saturating RF1 concentrations, however, does
not appear to change. Our data demonstrate that the
mutations in Ribo-X reduce the aﬃnity of the ribosome
for RF1 at the amber codon by a factor of  8-fold. This
may provide a mechanistic explanation for the increased
amber suppression activity observed in vivo.
DISCUSSION
In this work we have developed a puriﬁcation scheme to
isolate pure, homogenous and active tagged O-ribosomes.
We introduced a number of technical advances that allow
useful ribosomes to be puriﬁed following tagging. We
demonstrated the utility of this approach for making
in vitro measurements on O-ribosomes. Moreover, we
were able to make in vitro measurements on an evolved
O-ribosome and demonstrate that Ribo-X is likely to
enhance unnatural amino acid incorporation in response
to the amber codon in vivo by decreasing binding of RF1
to the amber codon/ribosome complex. In the future the
approach presented here may contribute to the detailed
molecular characterization of Ribo-X and O-ribosomes
that have been evolved to decode quadruplet codons for
genetic code expansion.
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